GSK
GSK
GSK
728 hedge funds and large institutions have $21.1B invested in GSK in 2014 Q4 according to their latest regulatory filings, with 106 funds opening new positions, 282 increasing their positions, 242 reducing their positions, and 70 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
17% more repeat investments, than reductions
Existing positions increased: 282 | Existing positions reduced: 242
4% more funds holding
Funds holding: 701 → 728 (+27)
0.24% less ownership
Funds ownership: 4.41% → 4.18% (-0.24%)
Holders
728
Holding in Top 10
9
Calls
$202M
Puts
$124M
Top Buyers
| 1 | +$227M | |
| 2 | +$114M | |
| 3 | +$77.8M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$71.1M |
| 5 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
+$60.2M |
Top Sellers
| 1 | -$740M | |
| 2 | -$625M | |
| 3 | -$289M | |
| 4 |
State Farm Mutual Automobile Insurance
Bloomington,
Illinois
|
-$105M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$97.9M |